Synthorx, Inc. Sample Contracts

● ] Shares Synthorx, Inc. UNDERWRITING AGREEMENT
Underwriting Agreement • November 27th, 2018 • Synthorx, Inc. • Pharmaceutical preparations • New York
Sample 1Sample 2Sample 3See All (628)
AutoNDA by SimpleDocs
INDEMNITY AGREEMENT
Indemnity Agreement • November 13th, 2018 • Synthorx, Inc. • Pharmaceutical preparations • Delaware

THIS INDEMNITY AGREEMENT (this “Agreement”) dated as of , 20 , is made by and between SYNTHORX, INC., a Delaware corporation (the “Company”), and (“Indemnitee”).

Sample 1Sample 2Sample 3See All (145)
AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT
Investors’ Rights Agreement • November 13th, 2018 • Synthorx, Inc. • Pharmaceutical preparations • Delaware

THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 12th day of April, 2018, by and among Synthorx, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A attached hereto, each of which is referred to in this Agreement as an “Investor” and any Additional Investor (as defined in Section 6.9 hereof) that becomes a party to this Agreement in accordance with Section 6.9 hereof.

Sample 1Sample 2Sample 3See All (86)
AGREEMENT AND PLAN OF MERGER among: Synthorx, Inc., a Delaware corporation; SANOFI, a French société anonyme; and Thunder Acquisition Corp., a Delaware corporation Dated as of December 7, 2019
Agreement and Plan of Merger • December 9th, 2019 • Synthorx, Inc. • Pharmaceutical preparations • Delaware

THIS AGREEMENT AND PLAN OF MERGER is made and entered into as of December 7, 2019, by and among: Sanofi, a French société anonyme (“Parent”); Thunder Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent (“Purchaser”); and Synthorx, Inc., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Exhibit A.

Sample 1Sample 2Sample 3See All (42)
11099 NORTH TORREY PINES ROAD LEASE
Lease • November 13th, 2018 • Synthorx, Inc. • Pharmaceutical preparations • California

This Lease (this “Lease”), dated as of the date set forth in Section 1 of the Summary of Basic Lease Information (the “Summary”), below, is made by and between HCP TORREY PINES, LLC, a Delaware limited liability company (“Landlord”), and SYNTHORX INC., a Delaware corporation (“Tenant”).

Sample 1Sample 2Sample 3See All (23)
CONFIDENTIALITY AGREEMENT
Confidentiality Agreement • December 23rd, 2019 • Synthorx, Inc. • Pharmaceutical preparations • Delaware

THIS CONFIDENTIALITY AGREEMENT (“Agreement”) is being entered into as of December 3, 2019, between SYNTHORX, INC., a Delaware corporation (the “Company”), and SANOFI, a French corporation (“Counterparty”).

Sample 1Sample 2Sample 3See All (9)
SYNTHORYX, INC. EMPLOYMENT AGREEMENT
Employment Agreement • November 13th, 2018 • Synthorx, Inc. • Pharmaceutical preparations • California

This Employment Agreement (this “Agreement”), is made and entered into as of July 14, 2017 (the “Effective Date”), by and between Marcos E. Milla, Ph.D. (“Employee”) and Synthorx, Inc. (the “Company”).

Sample 1Sample 2
SYNTHORX, INC. MASTER SERVICES AGREEMENT
Master Services Agreement • November 13th, 2018 • Synthorx, Inc. • Pharmaceutical preparations • Delaware

THIS MASTER SERVICES AGREEMENT (this “Agreement”) is entered into as of April 12, 2018 (the “Effective Date”), by and between SYNTHORX, INC., a Delaware corporation (“Synthorx”), with its principal place of business located at 11099 North Torrey Pines Road, Suite 290, La Jolla, CA 92037, USA, and CYTOVANCE BIOLOGICS, INC., an organization organized under the laws of Delaware (“Provider”), having its principal place of business located at 800 Research Parkway, Suite 200, Oklahoma City, OK 73104.

Sample 1Sample 2
SUPPORT SERVICES AGREEMENT
Support Services Agreement • November 13th, 2018 • Synthorx, Inc. • Pharmaceutical preparations • California

THIS SUPPORT SERVICES AGREEMENT (this “Agreement”) is made and entered into as of October 10, 2017 (the “Effective Date”), by and between SYNTHORX, INC., a Delaware Corporation (the “Company”), and COI PHARMACEUTICALS, INC., a Delaware Corporation (the “Service Provider”).

Sample 1Sample 2
LICENSE AGREEMENT by and between THE SCRIPPS RESEARCH INSTITUTE, a California nonprofit public benefit corporation and SYNTHORX, INC., a Delaware corporation
License Agreement • November 13th, 2018 • Synthorx, Inc. • Pharmaceutical preparations • California

THIS LICENSE AGREEMENT is entered into and made effective as of this 31st day of July, 2014 (the “Effective Date”), by and between THE SCRIPPS RESEARCH INSTITUTE, a California nonprofit public benefit corporation (“TSRI”) located at 10550 North Torrey Pines Road, La Jolla, California 92037, and SYNTHORX, INC., a Delaware corporation (“Licensee”) located at 11099 North Torrey Pines Road, Suite 290, La Jolla, California 92037, with respect to the facts set forth below.

Sample 1Sample 2
FIRST AMENDMENT TO LICENSE AGREEMENT
License Agreement • November 13th, 2018 • Synthorx, Inc. • Pharmaceutical preparations

This is an Amendment, dated as of September 10, 2018 (this “First Amendment”), to the License Agreement dated July 31, 2014 (the “Agreement”), by and between THE SCRIPPS RESEARCH INSTITUTE, a California nonprofit public benefit corporation (“TSRI”), and SYNTHORX, INC., a Delaware corporation (“Licensee”).

Sample 1Sample 2
RESEARCH FUNDING AND OPTION AGREEMENT
Research Funding and Option Agreement • November 13th, 2018 • Synthorx, Inc. • Pharmaceutical preparations • California

This Agreement is entered into this 31st day of July, 2014 (the “Effective Date”), by and between The Scripps Research Institute, a California nonprofit public benefit corporation located at 10550 North Torrey Pines Road, La Jolla, California 92037 (“TSRI”), and Synthorx, Inc., a Delaware corporation, located at 11099 North Torrey Pines Road, La Jolla, California 92037 (“Sponsor”), with respect to the facts set forth below.

Sample 1Sample 2
EXCLUSIVITY AGREEMENT
Exclusivity Agreement • December 23rd, 2019 • Synthorx, Inc. • Pharmaceutical preparations • Delaware

This Exclusivity Agreement (this “Agreement”) is entered into as of December 3, 2019, by and between Synthorx Inc, a Delaware corporation (the “Company”) and Sanofi (with its affiliates, “Counterparty”).

Sample 1Sample 2
Synthorx, Inc. 11099 N. Torrey Pines Road, Suite 190 La Jolla, CA 92037
Merger Agreement • January 7th, 2020 • Synthorx, Inc. • Pharmaceutical preparations

As you know, Synthorx, Inc. (the “Company”) has entered into an Agreement and Plan of Merger, dated December 7, 2019 (the “Merger Agreement”) with Sanofi, a French société anonyme (“Parent”) and Thunder Acquisition Corp., a wholly-owned subsidiary of Parent (“Merger Sub”). All capitalized terms used but not defined in this letter agreement shall be as set forth in the Merger Agreement.

Sample 1
FIRST AMENDMENT TO OFFICE SUBLEASE AGREEMENT
Office Sublease Agreement • November 13th, 2018 • Synthorx, Inc. • Pharmaceutical preparations

THIS FIRST AMENDMENT TO OFFICE SUBLEASE AGREEMENT (this “Amendment”) is entered into as of November 12, 2018 (the “Effective Date”), by and between COI PHARMACEUTICALS, INC., a Delaware corporation (“Sublandlord”), and SYNTHORX, INC., a Delaware corporation (“Subtenant”). Sublandlord and Subtenant may be referred to herein collectively as the “Parties” or individually as a “Party.”

Sample 1
SECOND AMENDMENT TO LICENSE AGREEMENT
License Agreement • November 5th, 2019 • Synthorx, Inc. • Pharmaceutical preparations

This is an Amendment, dated as of August 5, 2019 (this “Second Amendment”), to the License Agreement dated July 31, 2014, as amended on September 10, 2018 (collectively, the “Agreement”), by and between THE SCRIPPS RESEARCH INSTITUTE, a California nonprofit public benefit corporation (“TSRI”), and SYNTHORX, INC., a Delaware corporation (“Licensee”).

Sample 1
FIFTH AMENDMENT to RESEARCH FUNDING AND OPTION AGREEMENT
Funding and Option Agreement • November 5th, 2019 • Synthorx, Inc. • Pharmaceutical preparations

This Fifth Amendment (“Fifth Amendment”), entered into and made effective as of the last dated signature below (“Fifth Amendment Effective Date”), is made to RESEARCH FUNDING AND OPTION AGREEMENT dated July 31st, 2014, as amended on September 25, 2015, September 9, 2016, October 16, 2017, and August 16, 2018 (collectively, the “Agreement”) by and between THE SCRIPPS RESEARCH INSTITUTE, a California nonprofit public benefit corporation (“TSRI”), and SYNTHORX, INC., a Delaware corporation (“Sponsor”). Capitalized terms used but not defined herein shall have the same meanings set forth in the Agreement.

Sample 1
SUB-SUBLEASE (San Diego, California)
Sub-Sublease • November 5th, 2019 • Synthorx, Inc. • Pharmaceutical preparations • California

This Sub-Sublease (this “Sub-Sublease”) is entered into as of August 30, 2019 (the “Effective Date”), by and between Avelas Biosciences, Inc., a Delaware corporation (“Sub-Sublandlord”), and Synthorx, Inc., a Delaware corporation (“Sub-Subtenant”). Sub-Sublandlord and Sub-Subtenant may each be referred to herein as a “Party”, and collectively, the “Parties”.

Sample 1
Time is Money Join Law Insider Premium to draft better contracts faster.